Cargando…

Bioluminescent Zebrafish Transplantation Model for Drug Discovery

In the last decade, zebrafish have accompanied the mouse as a robust animal model for cancer research. The possibility of screening small-molecule inhibitors in a large number of zebrafish embryos makes this model particularly valuable. However, the dynamic visualization of fluorescently labeled tum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hason, Martina, Jovicic, Jovana, Vonkova, Ivana, Bojic, Milan, Simon-Vermot, Theresa, White, Richard M., Bartunek, Petr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086674/ https://www.ncbi.nlm.nih.gov/pubmed/35559262 http://dx.doi.org/10.3389/fphar.2022.893655

Ejemplares similares

Zebrafish Models of Cancer—New Insights on Modeling Human Cancer in a Non-Mammalian Vertebrate
por: Hason, Martina, et al.
Publicado: (2019)

Advances of Zebrafish in Neurodegenerative Disease: From Models to Drug Discovery
por: Wang, Xiaobo, et al.
Publicado: (2021)

M-CSFR/CSF1R signaling regulates myeloid fates in zebrafish via distinct action of its receptors and ligands
por: Hason, Martina, et al.
Publicado: (2022)

Orthogonal Drug Pooling Enhances Phenotype-Based Discovery of Ocular Antiangiogenic Drugs in Zebrafish Larvae
por: Ohnesorge, Nils, et al.
Publicado: (2019)

Combining Zebrafish and CRISPR/Cas9: Toward a More Efficient Drug Discovery Pipeline
por: Cornet, Carles, et al.
Publicado: (2018)

Bioluminescence Method for In Vitro Screening of Plasmodium Transmission-Blocking Compounds
por: Azevedo, Raquel, et al.
Publicado: (2017)

Zebrafish EEG predicts the efficacy of antiepileptic drugs
por: Shin, Jun-Nyeong, et al.
Publicado: (2022)

Transgenic Animal Models to Visualize Cancer-Related Cellular Processes by Bioluminescence Imaging
por: Manni, Isabella, et al.
Publicado: (2019)

Label-free drug discovery
por: Fang, Ye
Publicado: (2014)

New Hypoglycemic Drugs: Combination Drugs and Targets Discovery
por: Ni, Xiayun, et al.
Publicado: (2022)

Chemoinformatics Strategies for Leishmaniasis Drug Discovery
por: Ferreira, Leonardo L. G., et al.
Publicado: (2018)

Drug Discovery of DKK1 Inhibitors
por: Jiang, Hewen, et al.
Publicado: (2022)

Hematopoietic Cytokine Gene Duplication in Zebrafish Erythroid and Myeloid Lineages
por: Oltova, Jana, et al.
Publicado: (2018)

A chronic bioluminescent model of experimental visceral leishmaniasis for accelerating drug discovery
por: Álvarez-Velilla, Raquel, et al.
Publicado: (2019)

Murine infection with bioluminescent Leishmania infantum axenic amastigotes applied to drug discovery
por: Mendes Costa, David, et al.
Publicado: (2019)

The Grand Challenges in Cardiovascular Drug Discovery and Development
por: Ohlstein, Eliot H.
Publicado: (2010)

Limits of Prediction for Machine Learning in Drug Discovery
por: von Korff, Modest, et al.
Publicado: (2022)

Microglial Drug Targets in AD: Opportunities and Challenges in Drug Discovery and Development
por: Biber, Knut, et al.
Publicado: (2019)

Testing the Translational Power of the Zebrafish: An Interspecies Analysis of Responses to Cardiovascular Drugs
por: Margiotta-Casaluci, Luigi, et al.
Publicado: (2019)

Synthetic Biology Speeds Up Drug Target Discovery
por: Xie, Yixuan, et al.
Publicado: (2020)

From Genome to Drugs: New Approaches in Antimicrobial Discovery
por: Serral, Federico, et al.
Publicado: (2021)

Editorial: Insights in Experimental Pharmacology and Drug Discovery: 2021
por: Trostchansky, Andres, et al.
Publicado: (2022)

Editorial: Women in experimental pharmacology and drug discovery: 2021
por: Rižner, Tea Lanišnik, et al.
Publicado: (2022)

MBC and ECBL libraries: outstanding tools for drug discovery
por: Ginex, Tiziana, et al.
Publicado: (2023)

Editorial: Insights in experimental pharmacology and drug discovery: 2022
por: Latini, Alexandra, et al.
Publicado: (2023)

Three-Dimensional in Vitro Cell Culture Models in Drug Discovery and Drug Repositioning
por: Langhans, Sigrid A.
Publicado: (2018)

Interplay Between Angiotensin II Type 1 Receptor and Thrombin Receptor Revealed by Bioluminescence Resonance Energy Transfer Assay
por: Zamel, Isra Al, et al.
Publicado: (2020)

Trends in Antidiabetic Drug Discovery: FDA Approved Drugs, New Drugs in Clinical Trials and Global Sales
por: Dahlén, Amelia D., et al.
Publicado: (2022)

Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery
por: Imbrici, Paola, et al.
Publicado: (2016)

Drug Discovery via Human-Derived Stem Cell Organoids
por: Liu, Fangkun, et al.
Publicado: (2016)

QSAR-Based Virtual Screening: Advances and Applications in Drug Discovery
por: Neves, Bruno J., et al.
Publicado: (2018)

Editorial: New Paradigms in Neuroscience and Related Targets for Drug Discovery
por: Salomone, Salvatore
Publicado: (2020)

Editorial: Drug Development and Target Discovery in Pulmonary Vascular Diseases
por: Zhang, Rui, et al.
Publicado: (2020)

Unraveling Plant Natural Chemical Diversity for Drug Discovery Purposes
por: Lautié, Emmanuelle, et al.
Publicado: (2020)

Organoids and Microphysiological Systems: New Tools for Ophthalmic Drug Discovery
por: Bai, Jing, et al.
Publicado: (2020)

Strategy, Progress, and Challenges of Drug Repurposing for Efficient Antiviral Discovery
por: Li, Xinlei, et al.
Publicado: (2021)

Traditional Chinese Medicine and Colorectal Cancer: Implications for Drug Discovery
por: Sun, Qiang, et al.
Publicado: (2021)

Editorial: Antimycobacterial drug discovery: Molecular therapeutics and target identification
por: Gunosewoyo, Hendra, et al.
Publicado: (2022)

Editorial: Novel therapeutic target and drug discovery for neurological diseases
por: Zhao, Kaiyue, et al.
Publicado: (2022)

Editorial: Methods and application in experimental pharmacology and drug discovery: 2021
por: Polito, Letizia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pdpb556k4mnh2gbd3uil79kusi